INFI Annual CFI
-$55.00 K
-$5.54 M-101.00%
31 December 2022
Summary:
As of January 21, 2025, INFI annual cash flow from investing activities is -$55.00 thousand, with the most recent change of -$5.54 million (-101.00%) on December 31, 2022. During the last 3 years, it has risen by +$12.19 million (+99.55%).INFI Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
INFI Quarterly CFI
$0.00
$0.000.00%
30 June 2023
Summary:
As of January 21, 2025, INFI quarterly cash flow from investing activities is $0.00, unchanged on June 30, 2023. Over the past year, it has dropped by -$3.28 million (-100.00%).INFI Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
INFI TTM CFI
$10.73 M
-$3.28 M-23.41%
30 June 2023
Summary:
As of January 21, 2025, INFI TTM cash flow from investing activities is $10.73 million, with the most recent change of -$3.28 million (-23.41%) on June 30, 2023. Over the past year, it has increased by +$21.53 million (+199.39%).INFI TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
INFI Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -101.0% | -100.0% | +199.4% |
| 3 y3 years | +99.5% | -100.0% | +130.8% |
| 5 y5 years | +98.7% | -100.0% | +187.7% |
INFI Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | -100.0% | -100.0% | -93.4% |
Infinity Pharmaceuticals Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2023 | - | $0.00(0.0%) | $10.73 M(-23.4%) |
| Mar 2023 | - | $0.00(0.0%) | $14.01 M(<-9900.0%) |
| Dec 2022 | -$55.00 K(-101.0%) | $0.00(-100.0%) | -$55.00 K(0.0%) |
| Sept 2022 | - | $10.73 M(+227.2%) | -$55.00 K(-99.5%) |
| June 2022 | - | $3.28 M(-123.3%) | -$10.80 M(-23.3%) |
| Mar 2022 | - | -$14.07 M(<-9900.0%) | -$14.08 M(-356.5%) |
| Dec 2021 | $5.49 M(-62.5%) | $0.00(-100.0%) | $5.49 M(-75.8%) |
| Sept 2021 | - | -$11.00 K(<-9900.0%) | $22.71 M(+65.4%) |
| June 2021 | - | $0.00(-100.0%) | $13.73 M(-30.3%) |
| Mar 2021 | - | $5.50 M(-68.1%) | $19.70 M(+34.7%) |
| Dec 2020 | $14.63 M(-219.5%) | $17.22 M(-291.5%) | $14.63 M(+111.7%) |
| Sept 2020 | - | -$8.99 M(-250.5%) | $6.91 M(+48.7%) |
| June 2020 | - | $5.97 M(+1289.5%) | $4.65 M(-210.7%) |
| Mar 2020 | - | $430.00 K(-95.5%) | -$4.20 M(-65.7%) |
| Dec 2019 | -$12.24 M(-193.4%) | $9.50 M(-184.4%) | -$12.24 M(-43.7%) |
| Sept 2019 | - | -$11.26 M(+291.8%) | -$21.74 M(+6.4%) |
| June 2019 | - | -$2.87 M(-62.3%) | -$20.43 M(+6848.0%) |
| Mar 2019 | - | -$7.61 M(<-9900.0%) | -$294.00 K(-102.2%) |
| Dec 2018 | $13.10 M(-406.3%) | $0.00(-100.0%) | $13.10 M(+2.1%) |
| Sept 2018 | - | -$9.94 M(-157.6%) | $12.84 M(+1571.7%) |
| June 2018 | - | $17.26 M(+198.3%) | $768.00 K(-104.7%) |
| Mar 2018 | - | $5.79 M(-2283.4%) | -$16.49 M(+285.5%) |
| Dec 2017 | -$4.28 M(-110.6%) | -$265.00 K(-98.8%) | -$4.28 M(-41.1%) |
| Sept 2017 | - | -$22.01 M(<-9900.0%) | -$7.26 M(-127.8%) |
| June 2017 | - | $0.00(-100.0%) | $26.11 M(-67.7%) |
| Mar 2017 | - | $18.00 M(-654.9%) | $80.81 M(+100.4%) |
| Dec 2016 | $40.33 M(-206.4%) | -$3.24 M(-128.6%) | $40.33 M(+259.4%) |
| Sept 2016 | - | $11.35 M(-79.3%) | $11.22 M(-70.1%) |
| June 2016 | - | $54.71 M(-343.3%) | $37.47 M(-150.3%) |
| Mar 2016 | - | -$22.48 M(-30.5%) | -$74.52 M(+96.6%) |
| Dec 2015 | -$37.90 M(-132.2%) | -$32.35 M(-186.0%) | -$37.90 M(-247.2%) |
| Sept 2015 | - | $37.60 M(-165.6%) | $25.74 M(-280.8%) |
| June 2015 | - | -$57.29 M(-505.2%) | -$14.24 M(-113.8%) |
| Mar 2015 | - | $14.14 M(-54.8%) | $103.53 M(-12.2%) |
| Dec 2014 | $117.85 M(>+9900.0%) | $31.30 M(-1414.4%) | $117.85 M(-13.7%) |
| Sept 2014 | - | -$2.38 M(-103.9%) | $136.53 M(-16.0%) |
| June 2014 | - | $60.48 M(+112.5%) | $162.62 M(+101.2%) |
| Mar 2014 | - | $28.46 M(-43.1%) | $80.84 M(>+9900.0%) |
| Dec 2013 | $606.00 K(-101.0%) | $49.98 M(+110.8%) | $606.00 K(-100.9%) |
| Sept 2013 | - | $23.70 M(-211.3%) | -$64.97 M(-53.9%) |
| June 2013 | - | -$21.30 M(-58.9%) | -$140.97 M(+14.1%) |
| Mar 2013 | - | -$51.78 M(+232.0%) | -$123.56 M(+99.3%) |
| Dec 2012 | -$62.00 M(+352.9%) | -$15.60 M(-70.2%) | -$62.00 M(-28.6%) |
| Sept 2012 | - | -$52.30 M(+1246.6%) | -$86.87 M(+289.2%) |
| June 2012 | - | -$3.88 M(-139.7%) | -$22.32 M(+55.7%) |
| Mar 2012 | - | $9.79 M(-124.2%) | -$14.34 M(+4.7%) |
| Dec 2011 | -$13.69 M | -$40.47 M(-430.5%) | -$13.69 M(-136.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2011 | - | $12.24 M(+198.6%) | $37.42 M(+34.2%) |
| June 2011 | - | $4.10 M(-60.7%) | $27.89 M(-25.5%) |
| Mar 2011 | - | $10.43 M(-2.0%) | $37.41 M(+22.7%) |
| Dec 2010 | $30.48 M(-506.6%) | $10.64 M(+292.2%) | $30.48 M(+185.1%) |
| Sept 2010 | - | $2.71 M(-80.1%) | $10.69 M(-67.4%) |
| June 2010 | - | $13.62 M(+289.1%) | $32.77 M(+26.8%) |
| Mar 2010 | - | $3.50 M(-138.3%) | $25.85 M(-444.9%) |
| Dec 2009 | -$7.50 M(-58.8%) | -$9.15 M(-136.9%) | -$7.50 M(-83.9%) |
| Sept 2009 | - | $24.80 M(+269.9%) | -$46.44 M(+0.9%) |
| June 2009 | - | $6.70 M(-122.5%) | -$46.01 M(-24.6%) |
| Mar 2009 | - | -$29.85 M(-37.9%) | -$61.05 M(+235.7%) |
| Dec 2008 | -$18.18 M(-70.7%) | -$48.09 M(-290.6%) | -$18.18 M(-148.2%) |
| Sept 2008 | - | $25.23 M(-402.8%) | $37.69 M(+80.1%) |
| June 2008 | - | -$8.33 M(-164.0%) | $20.93 M(-16.7%) |
| Mar 2008 | - | $13.01 M(+67.2%) | $25.14 M(-140.5%) |
| Dec 2007 | -$62.01 M(-561.4%) | $7.78 M(-8.1%) | -$62.01 M(+1.4%) |
| Sept 2007 | - | $8.47 M(-305.3%) | -$61.13 M(-4.7%) |
| June 2007 | - | -$4.12 M(-94.4%) | -$64.15 M(+6.2%) |
| Mar 2007 | - | -$74.13 M(-956.1%) | -$60.42 M(-549.5%) |
| Dec 2006 | $13.44 M(-16.7%) | $8.66 M(+58.9%) | $13.44 M(+32.3%) |
| Sept 2006 | - | $5.45 M(-1480.5%) | $10.16 M(+189.8%) |
| June 2006 | - | -$394.70 K(+44.5%) | $3.51 M(-822.8%) |
| Mar 2006 | - | -$273.20 K(-105.1%) | -$485.00 K(-103.0%) |
| Dec 2005 | $16.13 M(+188.7%) | $5.38 M(-546.9%) | $16.13 M(-37.3%) |
| Sept 2005 | - | -$1.20 M(-72.6%) | $25.74 M(+0.7%) |
| June 2005 | - | -$4.39 M(-126.8%) | $25.55 M(+3.4%) |
| Mar 2005 | - | $16.34 M(+9.0%) | $24.71 M(+342.4%) |
| Dec 2004 | $5.59 M(-165.8%) | $14.99 M(-1174.5%) | $5.59 M(-160.2%) |
| Sept 2004 | - | -$1.39 M(-73.3%) | -$9.28 M(+0.4%) |
| June 2004 | - | -$5.22 M(+87.5%) | -$9.24 M(+29.3%) |
| Mar 2004 | - | -$2.78 M(-2341.6%) | -$7.15 M(-15.8%) |
| Dec 2003 | -$8.49 M(-78.6%) | $124.20 K(-109.1%) | -$8.49 M(-24.3%) |
| Sept 2003 | - | -$1.36 M(-56.5%) | -$11.22 M(-53.5%) |
| June 2003 | - | -$3.13 M(-24.3%) | -$24.11 M(-40.3%) |
| Mar 2003 | - | -$4.13 M(+58.4%) | -$40.39 M(+1.9%) |
| Dec 2002 | -$39.65 M(-12.8%) | -$2.61 M(-81.7%) | -$39.65 M(+11.7%) |
| Sept 2002 | - | -$14.25 M(-26.6%) | -$35.50 M(-10.2%) |
| June 2002 | - | -$19.41 M(+473.4%) | -$39.54 M(+19.1%) |
| Mar 2002 | - | -$3.38 M(-319.4%) | -$33.19 M(-27.0%) |
| Dec 2001 | -$45.45 M(+393.8%) | $1.54 M(-108.4%) | -$45.45 M(-10.6%) |
| Sept 2001 | - | -$18.29 M(+40.0%) | -$50.86 M(+53.6%) |
| June 2001 | - | -$13.06 M(-16.5%) | -$33.11 M(+51.3%) |
| Mar 2001 | - | -$15.64 M(+304.6%) | -$21.88 M(+137.7%) |
| Dec 2000 | -$9.20 M(+56.2%) | -$3.87 M(+615.6%) | -$9.20 M(+72.4%) |
| Sept 2000 | - | -$540.30 K(-70.4%) | -$5.34 M(+11.3%) |
| June 2000 | - | -$1.83 M(-38.5%) | -$4.80 M(+61.5%) |
| Mar 2000 | - | -$2.97 M | -$2.97 M |
| Dec 1999 | -$5.89 M | - | - |
FAQ
- What is Infinity Pharmaceuticals annual cash flow from investing activities?
- What is the all time high annual CFI for Infinity Pharmaceuticals?
- What is Infinity Pharmaceuticals annual CFI year-on-year change?
- What is Infinity Pharmaceuticals quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Infinity Pharmaceuticals?
- What is Infinity Pharmaceuticals quarterly CFI year-on-year change?
- What is Infinity Pharmaceuticals TTM cash flow from investing activities?
- What is the all time high TTM CFI for Infinity Pharmaceuticals?
- What is Infinity Pharmaceuticals TTM CFI year-on-year change?
What is Infinity Pharmaceuticals annual cash flow from investing activities?
The current annual CFI of INFI is -$55.00 K
What is the all time high annual CFI for Infinity Pharmaceuticals?
Infinity Pharmaceuticals all-time high annual cash flow from investing activities is $117.85 M
What is Infinity Pharmaceuticals annual CFI year-on-year change?
Over the past year, INFI annual cash flow from investing activities has changed by -$5.54 M (-101.00%)
What is Infinity Pharmaceuticals quarterly cash flow from investing activities?
The current quarterly CFI of INFI is $0.00
What is the all time high quarterly CFI for Infinity Pharmaceuticals?
Infinity Pharmaceuticals all-time high quarterly cash flow from investing activities is $60.48 M
What is Infinity Pharmaceuticals quarterly CFI year-on-year change?
Over the past year, INFI quarterly cash flow from investing activities has changed by -$3.28 M (-100.00%)
What is Infinity Pharmaceuticals TTM cash flow from investing activities?
The current TTM CFI of INFI is $10.73 M
What is the all time high TTM CFI for Infinity Pharmaceuticals?
Infinity Pharmaceuticals all-time high TTM cash flow from investing activities is $162.62 M
What is Infinity Pharmaceuticals TTM CFI year-on-year change?
Over the past year, INFI TTM cash flow from investing activities has changed by +$21.53 M (+199.39%)